Main Topics e Abstract Tracks - 19° Congresso Nazionale ICAR,...

I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV;...

I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis I Main Topics e le Abstract Tracks di ICAR 2027: Ageing and HIV; Antiretroviral therapy; Clinical pharmacology; Epidemiology, HIV testing, cascade of care; Hepatitis/MASLD and other liver diseases; HIV-related cancers; HIV latency, reservoir and cure; HIV neuropathogenesis, and mental health; HIV resistance and advanced diagnostics; Immunology, host immune response, and inflammation; Late presentation, HIV advanced disease, and opportunistic infections; Long-acting ARV agents and new therapeutic scenarios; Metabolic, cardiovascular, and other non-communicable diseases; Other complications of HIV Infection and antiretroviral therapy; Pediatric and adolescents; PrEP, PEP, and other prevention strategies; SARS-CoV-2 infection and complications; Social sciences and PROs; STI (syphilis, chlamydia, gonorrhea, mpox); Vaccines and immunotherapies; Virology and HIV pathogenesis